Health Care & Life Sciences » Pharmaceuticals | Taiko Pharmaceutical Co. Ltd.

Taiko Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
8,543
6,119
2,997
6,803
6,548
7,225
Total Accounts Receivable
2,178
1,863
2,196
1,821
3,362
3,619
Inventories
1,706
2,181
1,757
1,385
1,525
1,540
Other Current Assets
475
315
482
267
330
188
Total Current Assets
12,901
10,478
7,433
10,276
11,764
12,572
Net Property, Plant & Equipment
2,857
7,628
8,410
8,076
7,895
7,371
Total Investments and Advances
312
-
-
-
332
741
Intangible Assets
35
32
48
47
92
238
Other Assets
393
370
311
306
282
277
Total Assets
16,622
18,599
16,307
18,789
20,473
21,600
ST Debt & Current Portion LT Debt
13
13
14
15
14
Accounts Payable
497
350
239
302
424
Income Tax Payable
907
610
249
361
333
Other Current Liabilities
2,730
4,031
1,505
1,558
2,045
Total Current Liabilities
4,147
5,004
2,008
2,237
2,816
Long-Term Debt
28
36
28
19
15
Provision for Risks & Charges
479
523
565
582
655
Deferred Taxes
125
92
106
85
107
Other Liabilities
563
563
567
567
567
Total Liabilities
5,216
6,126
3,168
3,404
4,053
Common Equity (Total)
11,406
12,473
13,140
15,385
16,420
Total Shareholders' Equity
11,406
12,473
13,140
15,385
16,420
Total Equity
11,406
12,473
13,140
15,385
16,420
Liabilities & Shareholders' Equity
16,622
18,599
16,307
18,789
20,473

About Taiko Pharmaceutical Co.

View Profile
Address
ORIX Honmachi Building, 16F
Osaka Osaka 550
Japan
Employees -
Website http://www.seirogan.co.jp
Updated 07/08/2019
Taiko Pharmaceutical Co., Ltd. engages in the manufacture and sale of general medications particularly non-prescription gastrointestinal drugs and designated quasi drugs, and sanitation control products. It operates through the following segments: Pharmaceuticals, Infection Control, and Others. The Pharmaceuticals segment handles the manufacture, procurement and sale of non-prescription (OTC) drugs in Japan and overseas.